TrialHuman vaccines & immunotherapeutics2023

Safety and immunogenicity of a 15-valent pneumococcal conjugate vaccine in Japanese healthy infants: A Phase I study (V114-028).

Yasunori Ishihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.